# CF WARRIORS

## Details

- **Country:** England &amp; Wales
- **Charity number:** 1178063
- **Status:** Registered
- **Legal form:** CIO
- **Registered:** April 24, 2018
- **Register:** https://register-of-charities.charitycommission.gov.uk/en/charity-search/?p_p_id=uk_gov_ccew_onereg_charitydetails_web_portlet_CharityDetailsPortlet&amp;p_p_lifecycle=0&amp;p_p_state=maximized&amp;p_p_mode=view&amp;_uk_gov_ccew_onereg_charitydetails_web_portlet_CharityDetailsPortlet_regId=1178063


## Contact

- **Address:** Unit 1, Chorley, Penllyn Estate Farm, Cowbridge, Vale of Glamorgan
- **Postcode:** UK
- **Phone:** 07468 599784
- **Email:** INFO@CFWARRIORS.ORG.UK
- **Website:** www.cfwarriors.org.uk



## Activities

**Objects:** FOR THE PUBLIC BENEFIT, THE RELIEF OF SICKNESS AND THE PRESERVATION OF HEALTH AMONG PEOPLE WITH CYSTIC FIBROSIS BY:A) PROVIDING GOODS AND/OR EQUIPMENT THAT CAN BE USED TO AID THE FITNESS AND HEALTH OF PEOPLE WITH CYSTIC FIBROSIS AND SUPPORT AND PRACTICAL ADVICE FOR CARRYING OUT APPROPRIATE FORMS OF EXERCISE;B) PROVIDING FUNDING FOR RESEARCH INTO CYSTIC FIBROSIS, IN PARTICULAR THE TREATMENT OF CYSTIC FIBROSIS AND THE EFFECTS OF EXERCISE ON PEOPLE WITH CYSTIC FIBROSIS.

**Activities:** The charity&#x27;s main activities are:a) We provide Warrior Packs that contain goods and/or equipment that can be used to aid the fitness and health of people with cystic fibrosis; b) We fund research into cystic fibrosis, in particular the effects of exercise on people with cystic fibrosis and any treatments that can potentially aid recovery before, during and after exercise.




## Classification

- **How:** Other Charitable Activities
- **What:** General Charitable Purposes, Disability
- **Who:** Children/young People, People With Disabilities



## Geography

- Throughout England And Wales





## Trustees

| Name | Role | Appointed |
|---|---|---|
| **JOSH LLEWELLYN-JONES OBE** | Chair | April 24, 2018 |
| Dr PAUL LANGMAID CBE |  | April 24, 2018 |
| James Alexander Gadd |  | Feb. 26, 2024 |
| Stephen Doyle |  | Feb. 5, 2020 |




